Hysterectomy Clinical Trials

Clinical trials related to Hysterectomy Procedure

Effect of Preventive Analgesia by Injection of a Local Anesthetic Before Vaginal Incision for Hysterectomy by vNOTES Approach: Randomized, Double-blind Study

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other, Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY

The research procedure is the injection of 20 mL of Ropivacaine solution (vs. saline) to create a paracervical block at the beginning of surgery, while the patient is already under general anesthesia. This injection will take place 3 minutes before the vaginal incision, via 4 injection points. Injections are made 3 mm deep into the vaginal cul de sac. Randomization takes place before surgery by vNOTES: * Experienced group: Local anesthesia with injection of Ropivacaine (20mL of ropivacaine 7.5 mg/mL, i.e. 150mg) and general anesthesia * Control group: Injection of 20mL of placebo (saline) and general anesthesia In both groups, systematic intraoperative and postoperative analgesia will be identical.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:

• Adult patients aged 18 to 70 inclusive

• Patient scheduled for vNOTES surgery for total hysterectomy for benign pathology, whether or not associated with an adnexal procedure (unilateral or bilateral salpingectomy or adnexectomy (for cysts smaller than 6 cm)).

• Person having read and understood the information letter and signed the consent form

• Person affiliated to a social security scheme

Locations
Other Locations
France
Gh Le Havre
RECRUITING
Le Havre
Chu Rouen
RECRUITING
Rouen
Contact Information
Primary
Patrice Crochet, Dr
Patrice.Crochet@chu-rouen.fr
06 88 38 48 03
Time Frame
Start Date: 2025-09-16
Estimated Completion Date: 2029-09-01
Participants
Target number of participants: 108
Treatments
Experimental: Experienced group
Administration of Naropeine
Placebo_comparator: Control group
Administration of a saline solution
Related Therapeutic Areas
Sponsors
Collaborators: Groupe Hospitalier du Havre
Leads: University Hospital, Rouen

This content was sourced from clinicaltrials.gov